Related references
Note: Only part of the references are listed.Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
Mitochondrial carnitine palmitoyltransferase 2 is involved in Nε-(carboxymethyl)-lysine-mediated diabetic nephropathy
Jangho Lee et al.
PHARMACOLOGICAL RESEARCH (2020)
SARS-CoV-2-mediated inflammatory response in lungs: should we look at RAGE?
Armando Rojas et al.
INFLAMMATION RESEARCH (2020)
Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction
Ami Sotokawauchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Advances in SARS-CoV-2: a systematic review
Y-X Bai et al.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES (2020)
Soluble Receptor for Advanced Glycation End Products: A Protective Molecule against Intramyocardial Lipid Accumulation in Obese Zucker Rats?
Elena Dozio et al.
MEDIATORS OF INFLAMMATION (2019)
Sarcopenia is Associated with Malnutrition but Not with Systemic Inflammation in Older Persons with Advanced CKD
Simone Vettoretti et al.
NUTRIENTS (2019)
Malnutrition and inflammation are associated with severity of depressive and cognitive symptoms of old patients affected by chronic kidney disease
Dalila Guenzani et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2019)
Methylglyoxal as a prognostic factor in patients with chronic kidney disease
Yuta Tezuka et al.
NEPHROLOGY (2019)
Usefulness of glycated albumin as a biomarker for glucose control and prognostic factor in chronic kidney disease patients on dialysis (CKD-G5D)
Elena Dozio et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Advanced glycation end products in the pathogenesis of chronic kidney disease
Naila Rabbani et al.
KIDNEY INTERNATIONAL (2018)
Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys
Heba Al-Hussaini et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Glycaemic control in type 2 diabetic patients with chronic kidney disease: the impacts on enzymatic antioxidants and soluble RAGE
Foo Nian Wong et al.
PEERJ (2018)
Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant
Jesus Calvino et al.
PLOS ONE (2018)
Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
Elena Dozio et al.
MEDIATORS OF INFLAMMATION (2018)
Relationship between soluble receptor for advanced glycation end products (sRAGE), body composition and fat distribution in healthy women
Elena Dozio et al.
EUROPEAN JOURNAL OF NUTRITION (2017)
Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
Elena Dozio et al.
MEDIATORS OF INFLAMMATION (2017)
Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients
Alexis Guerin-Dubourg et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Inflammation and premature aging in advanced chronic kidney disease
Jeroen P. Kooman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Glycated albumin: from biochemistry and laboratory medicine to clinical practice
Elena Dozio et al.
ENDOCRINE (2017)
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension
Ernesto Paoletti et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease
Anna Machowska et al.
PLOS ONE (2016)
Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study
Mariana Lazo et al.
AMERICAN HEART JOURNAL (2015)
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
Martin Heier et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes
Merlin C. Thomas et al.
DIABETES CARE (2015)
Vascular Effects of Advanced Glycation End-Products: Content of Immunohistochemically Detected AGEs in Radial Artery Samples as a Predictor for Arterial Calcification and Cardiovascular Risk in Asymptomatic Patients with Chronic Kidney Disease
Katarzyna Janda et al.
DISEASE MARKERS (2015)
Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes
Alan C. H. Lee et al.
PLOS ONE (2015)
Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study
Casey M. Rebholz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels
Hyung Soo Kim et al.
NEPHROLOGY (2013)
Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis
Jwa-Kyung Kim et al.
ATHEROSCLEROSIS (2012)
Decreased serum endogenous secretory receptor for advanced glycation endproducts and increased cleaved receptor for advanced glycation endproducts levels in patients with atrial fibrillation
Dongdong Zhao et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells
Valentina Masola et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease
Giuseppina Basta et al.
KIDNEY INTERNATIONAL (2010)
Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases
Helene Maillard-Lefebvre et al.
RHEUMATOLOGY (2009)
Identification, classification, and expression of RAGE gene splice variants
Barry I. Hudson et al.
FASEB JOURNAL (2008)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
AGE, RAGE, and ROS in diabetic nephropathy
Adeline L. Y. Ton et al.
SEMINARS IN NEPHROLOGY (2007)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
Soluble receptor for advanced glycation end products in patients with decreased renal function
M Kalousová et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Diabetes mellitus exacerbates advanced glycation end product accumulation in the veins of end-stage renal failure patients
N. Nazratuna et al.
VASCULAR MEDICINE (2006)
Advanced glycation endproducts - role in pathology of diabetic complications
N Ahmed
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Tissue-specific expression patterns of the RAGE receptor and its soluble forms - a result of regulated alternative splicing?
C Schlueter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2003)
A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients
K Kalantar-Zadeh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy
T Shimoike et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Share Paper
